Lv3
266 积分 2023-04-18 加入
Overcoming Primary and Acquired Resistance to Immunotherapy in Non–Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies
4天前
已完结
Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer
4天前
已完结
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic Cells
4天前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
4天前
已完结
The next generation of antibody–drug conjugates
27天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
1个月前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
1个月前
已完结
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases
1个月前
已完结
Redefining first-line standards with new partners
1个月前
已完结
Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
2个月前
已完结
皖公网安备34019202002308
